<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04136210</url>
  </required_header>
  <id_info>
    <org_study_id>Heart Registry</org_study_id>
    <nct_id>NCT04136210</nct_id>
  </id_info>
  <brief_title>Registry Construction for Perioperative Data in Patients Undergoing Cardiovascular Surgery</brief_title>
  <official_title>Perioperative Clinical, Hemodynamic Data and Prognosis Assessment in Patients Who Undergo Cardiovascular Surgery; Registry Construction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this registry is to obtain perioperative data in patients undergoing cardiac
      or thoracic aortic surgery and find out relations between the data and investigate several
      causes affecting postoperative complications.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 19, 2019</start_date>
  <completion_date type="Anticipated">May 19, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 19, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Baseline characteristics</measure>
    <time_frame>Before surgery</time_frame>
    <description>Sex
Age
Height
Weight
Body mass index
Underlying disease Family history
Previous operation history
Current medication Preoperative hemodialysis
Preoperative cardiopulmonary resuscitation
Preoperative mechanical ventilation
Preoperative intra-aortic balloon pump
Preoperative intravenous drug and dose
Alcohol history, smoking history
Drug allergy
Functional capacity, ASA classification, NYHA class
EuroSCORE, STS score, SOFA score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Preoperative data</measure>
    <time_frame>Before surgery</time_frame>
    <description>Vital sign including systolic blood pressure, diastolic blood pressure, mean blood pressure, pulse pressure, heart rate, SpO2, body temperature, consciousness, GCS (Glasgow Coma Scale), central venous pressure, pulmonary arterial pressure, and respiratory rate
Laboratory data including CBC (Hb, Hct, WBC, platelet), Electrolyte (Na, K, Ca, Mg), coagulation (PT INR, aPTT, fibrinogen), ABGA (Hct, pH, pCO2, pO2, HCO3-, BE, SaO2), BUN/Creatinine, OT/PT, Total bilirubin, CRP, cardiac enzyme (Troponin I, CK, CK-MB), albumin, glucose, HbA1C, lactate, and creatinine clearance
ABGA (Hct, pH, pCO2, pO2, HCO3-, BE, SaO2, Na, K, iCa, Glucose, Lactic acid)
Imaging data including chest X-ray, chest CT, Brain MRI/A, coronary angiography, CT angiography, cardiac MRI, myocardiac SPECT, and abdomen CT
ECG (rhythm, QTc interval), PFT, Echocardiography (Ejection fraction, RWMA, Pulmonary HTN, Valve abnormality), and esophagogastroduodenoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraoperative and postoperative data</measure>
    <time_frame>During surgery and until 48 hours after surgery</time_frame>
    <description>Vital sign
ECG analysis
Stroke volume variation, pulse pressure variation
Cardiac index, cardiac output, stroke volume, mixed venous oxygen saturation
Airway and respiratory indicators
Bispectral index
Patient state index (PSi)
Tissue oxygen saturation of brain and limbs
Tissue oxygen saturation (StO2) during vascular occlusion test (VOT)
Transcutaneous CO2 (PtcCO2), transcutaneous O2 (PtcO2)
Sublingual SDF imaging (MicroScan; MicroVision Medical, Amsterdam, the Netherlands)
Pupil reactivity assessment scale
Coagulation: ROTEM, Multiplate
Laboratory data
ABGA
Cardiac enzyme</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Operation data</measure>
    <time_frame>During surgery</time_frame>
    <description>Type of operation
Emergency or elective
Types and doses of anesthetics, anesthesia time, surgery time
Location of arterial lines
Infused fluid and dose, estimated blood loss, blood transfusion, and urine output
Coronary artery bypass surgery: type of bypass artery, bypass time for each artery
Cardiopulmonary bypass A. Cardiopulmonary bypass protocol B. Types and doses of used drug, rewarming time, duration of CPB, time of aortic clamping, transfusion dose
Aortic arch surgery: total circulatory arrest, circulatory arrest duration, cerebral perfusion
Intraoperative TEE finding
Assist device including IABP, ECMO, LVAD, and RVAD
Rescue drug usage and dose
Tranexamic acid and vitamin K usage
Drug reaction or specific event</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative ICU data</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Imaging data including chest X-ray, chest CT, Brain MR/CT, Echocardiography
Mechanical ventilation duration
ICU stay duration
Hospital stay duration
Postoperative pain control, sedatives
Drug usage and dose (Epinephrine, norepinephrine, dobutamine, dopamine, milrinone, vasopressin, nitroglycerin, phenylephrine, calcium chloride, lidocaine, amiodarone, digoxin, diltiazem, bicarbonate, and adenosine)
Assist device including IABP, ECMO, LVAD, and RVAD
Infused fluid and dose (crystalloid, colloid), estimated blood loss, blood transfusion (RBC, FFP, Platelet, cryoprecipitate, self-blood salvage), urine output at ICU admission, 24 hours / 48 hours after ICU admission.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Cardiac complications
Respiratory complications
Neurologic complications
Renal complications
Infectious complications
Gastrointestinal complications
Adverse drug reaction
Bleeding complications
Thrombotic complications
Postoperative multiorgan failure (SOFA score)
Mortality including in hospital mortality
Re-operation</description>
  </primary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Cardiac Surgery</condition>
  <condition>Anesthesia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients undergoing cardiac or thoracic aortic surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing cardiac or thoracic aortic surgery

        Exclusion Criteria:

          -  refused to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunseok Jeon, MD, PhD</last_name>
      <phone>82-2-2072-2467</phone>
      <email>jeonyunseok@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Yunseok Jeon, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 13, 2019</study_first_submitted>
  <study_first_submitted_qc>October 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2019</study_first_posted>
  <last_update_submitted>October 22, 2019</last_update_submitted>
  <last_update_submitted_qc>October 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Yunseok Jeon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

